glp-1 ras mechanism of action of [25] A schematic representation of the
Description
doi: 10.1111/obr.12815
And while we shouldnt reject a therapy just because its potent, we also shouldnt race ahead without asking: potent enough for whatand for how long
![glp-1 ras mechanism of action of [25] A schematic representation of the](https://www.frontiersin.org/files/Articles/543516/xml-images/fphar-11-00967-g001.webp)
(2023, January 5)
![glp-1 ras mechanism of action of [25] A schematic representation of the](https://medrac.web.unc.edu/wp-content/uploads/sites/22579/2025/03/image-6.png)
The boys started with .25 milligrams of Wegovy before moving up to .5 milligrams and then, in May, switched to a 1 milligram weekly shot
![glp-1 ras mechanism of action of [25] A schematic representation of the](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41440-025-02418-2/MediaObjects/41440_2025_2418_Figa_HTML.png)
Victoza a GLP-1 for diabetes is expected to lose patent protection in 2024
![glp-1 ras mechanism of action of [25] A schematic representation of the](https://www.frontiersin.org/files/Articles/721135/xml-images/fendo-12-721135-g001.webp)